Chan Ding-Cheng Derrick, Hao Yi-Ting, Wu Shwu-Chong
Department of Geriatrics, National Taiwan University Hospital, Taipei, Taiwan.
Drugs Aging. 2009;26(4):345-54. doi: 10.2165/00002512-200926040-00005.
It is not known whether the correlates of polypharmacy among disabled elderly are similar to those for older adults in general. Furthermore, data on polypharmacy in the Taiwanese population are limited. Therefore, this study was conducted to determine the prevalence and correlates of polypharmacy among disabled Taiwanese elderly (aged >or=65 years).
This was a longitudinal observational study conducted on information obtained between July 2001 and June 2002. Study participants consisted of nationally representative samples of 11,788 disabled Taiwanese elderly from the ANLTCNT (Assessment of National Long-Term Care Need in Taiwan) study. Polypharmacy and major polypharmacy were defined as prescription of >or=5 and >or=10 medications, respectively, on the day of maximum numbers of prescriptions of the study year. Subject characteristics were derived from the ANLTCNT study survey data. Healthcare-related characteristics, including medication prescriptions, were obtained from the National Health Insurance (NHI) claims data. Multivariate logistic regression was performed for statistical analysis.
One-fifth (21.5%) of the sample were aged >or=85 years, and 58% were female. The prevalence of polypharmacy and major polypharmacy among disabled Taiwanese elderly was 81% and 38%, respectively. Nearly one-third (32.5%) of disabled Taiwanese elderly were exposed to polypharmacy for >or=181 days in 1 year. Compared with those with a low tendency for visiting multiple providers, those with intermediate tendency (odds ratio [OR] 3.61; 95% CI 3.11, 4.18) and those with high tendency (OR 10.24; 95% CI 8.56, 12.24) were more likely to be exposed to polypharmacy. Other significant correlates of polypharmacy in the multivariate logistic regression model included age <85 years, living in urban areas, higher number of chronic conditions, poorer physical functioning, preference for visiting independent clinics and not being institutionalized.
The prevalence of polypharmacy was extremely high among disabled Taiwanese elderly. Visiting multiple healthcare providers was one of the strongest correlates. Policies that encourage the disabled elderly to establish primary care relationships and that promote geriatric care models may decrease the prevalence of polypharmacy and associated adverse outcomes in this group.
目前尚不清楚残疾老年人多重用药的相关因素是否与一般老年人相似。此外,台湾人群中多重用药的数据有限。因此,本研究旨在确定台湾残疾老年人(年龄≥65岁)多重用药的患病率及其相关因素。
这是一项纵向观察性研究,基于2001年7月至2002年6月期间获取的信息开展。研究参与者包括来自台湾长期照护需求评估(ANLTCNT)研究的11788名具有全国代表性的台湾残疾老年人样本。多重用药和严重多重用药分别定义为在研究年度处方数量最多的那天开具≥5种和≥10种药物。受试者特征来自ANLTCNT研究调查数据。医疗相关特征,包括用药处方,来自国民健康保险(NHI)理赔数据。进行多因素逻辑回归分析。
样本中五分之一(21.5%)的人年龄≥85岁,58%为女性。台湾残疾老年人中多重用药和严重多重用药的患病率分别为81%和38%。近三分之一(32.5%)的台湾残疾老年人在1年中多重用药天数≥181天。与看多个医疗机构倾向较低的人相比,看多个医疗机构倾向中等的人(比值比[OR] 3.61;95%可信区间[CI] 3.11,4.18)和倾向较高的人(OR 10.24;95% CI 8.56,12.24)更有可能多重用药。多因素逻辑回归模型中多重用药的其他显著相关因素包括年龄<85岁、居住在城市地区、慢性病数量较多、身体功能较差、偏爱看独立诊所且未入住机构。
台湾残疾老年人中多重用药的患病率极高。看多个医疗机构是最主要的相关因素之一。鼓励残疾老年人建立初级保健关系并推广老年护理模式的政策可能会降低该群体中多重用药的患病率及相关不良后果。